Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Hilda Razzaghi, Katherine E Kahn, Kayla Calhoun, Emma Garacci, Tami H Skoff, Sascha R Ellington, Tara C Jatlaoui, Carla L Black
Influenza, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap), and COVID-19 vaccines can reduce the risk for influenza, pertussis, and COVID-19 among pregnant women and their infants. To assess influenza, Tdap, and COVID-19 vaccination coverage among women pregnant during the 2022-23 influenza season, CDC analyzed data from an Internet panel survey conducted during March 28-April 16, 2023. Among 1,814 survey respondents who were pregnant at any time during October 2022-January 2023, 47...
September 29, 2023: MMWR. Morbidity and Mortality Weekly Report
#2
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 29, 2023: MMWR. Morbidity and Mortality Weekly Report
#3
JOURNAL ARTICLE
Hanna M Shephard, Susan E Manning, Eirini Nestoridi, Anne Marie Darling, Catherine M Brown, Megan Hatch, Kathryn Ahnger-Pier, Sharon Pagnano, Darien Mather, Mahsa M Yazdy
National estimates suggest that COVID-19 vaccination coverage among pregnant persons is lower among those identifying as Hispanic or Latino (Hispanic) and non-Hispanic Black or African American. When examining COVID-19 vaccination coverage during pregnancy by race and ethnicity, however, data are typically limited to large, aggregate categories that might obscure within-group inequities. To address this, Massachusetts examined COVID-19 vaccination coverage among pregnant persons by combinations of 12 racial and 34 ethnic groupings...
September 29, 2023: MMWR. Morbidity and Mortality Weekly Report
#4
(no author information available yet)
No abstract text is available yet for this article.
September 29, 2023: MMWR. Morbidity and Mortality Weekly Report
#5
JOURNAL ARTICLE
Mehreen Meghani, Beatriz Salvesen Von Essen, Lauren B Zapata, Kara Polen, Romeo R Galang, Hilda Razzaghi, Dana Meaney-Delman, Grayson Waits, Sascha Ellington
Pregnant and postpartum women are at increased risk for severe illness from COVID-19 compared with nonpregnant women of reproductive age. COVID-19 vaccination is recommended for all persons ≥6 months of age. Health care providers (HCPs) have a unique opportunity to counsel women of reproductive age, including pregnant and postpartum patients, about the importance of receiving COVID-19, influenza, and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines. Data from the Fall 2022 DocStyles survey were analyzed to examine the prevalence of COVID-19 vaccination attitudes and practices among HCPs caring for women of reproductive age, and to determine whether providers recommended and offered or administered COVID-19 vaccines to women of reproductive age, including their pregnant patients...
September 29, 2023: MMWR. Morbidity and Mortality Weekly Report
#6
JOURNAL ARTICLE
Lakshmi Radhakrishnan, Kelly Carey, Dylan Pell, Amy Ising, Danielle Brathwaite, Anna Waller, James Gay, Hollie Watson-Smith, Mark Person, Kenan Zamore, Tia Brumsted, Claudia Price, Patti M Clark, Gabriel Ann Haas, Lauren Gracy, Scott Johnston, Yushiuan Chen, Kyla Muñoz, Meredith Henry, Brittany Willis, Darryl Nevels, Ibitola Asaolu, Sarah Lee, Natalie J Wilkins, Sarah Bacon, Michael Sheppard, Aaron Kite-Powell, Gary Blau, Michael King, Meghan Whittaker, Rebecca T Leeb
Mental and behavioral health conditions among school-aged children, including substance use disorders and overall emotional well-being, are a public health concern in the United States. Timely data on seasonal patterns in child and adolescent conditions can guide optimal timing of prevention and intervention strategies. CDC examined emergency department (ED) visit data from the National Syndromic Surveillance Program for 25 distinct conditions during January 2018-June 2023 among U.S. children and adolescents aged 5-17 years, stratified by age group...
September 22, 2023: MMWR. Morbidity and Mortality Weekly Report
#7
JOURNAL ARTICLE
Adam Bjork, Irfan Elahi Akbar, Sumangala Chaudhury, Mufti Zubair Wadood, Fazal Ather, Jaume Jorba, Maureen Martinez
When the Global Polio Eradication Initiative began in 1988, wild poliovirus (WPV) transmission was reported in 125 countries. Since 2017, Afghanistan and Pakistan remain the only countries with uninterrupted endemic WPV type 1 (WPV1) transmission. This report describes activities and progress toward polio eradication in Afghanistan during January 2022-June 2023. Two WPV1 cases were reported during January-December 2022 and five during January-June 2023 (as of August 26), all from three provinces in the southeast and east regions bordering Pakistan...
September 22, 2023: MMWR. Morbidity and Mortality Weekly Report
#8
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 22, 2023: MMWR. Morbidity and Mortality Weekly Report
#9
JOURNAL ARTICLE
Emily W Hogeland, Tarah S Somers, Luke Yip, Suzanne Doyon, Carrie A Redlich, Andrea D Orsey, Craig B Woda, Suzannah T Swan, Henry M Feder
Two siblings aged 5 and 15 years from Connecticut were hospitalized with petechial rash, oral mucositis, and severe thrombocytopenia approximately 10 days after they played with a jar of elemental mercury they found in their home. Before the mercury exposure was disclosed, the siblings were treated with platelet transfusions, intravenous immune globulin (IVIG) for possible immune thrombocytopenic purpura, and antibiotics for possible infectious causes. When their conditions did not improve after 6 days, poison control facilitated further questioning about toxic exposures including mercury, testing for mercury, and chelation with dimercaptosuccinic acid...
September 22, 2023: MMWR. Morbidity and Mortality Weekly Report
#10
JOURNAL ARTICLE
Elizabeth Davlantes, Jaume Jorba, Elizabeth Henderson, Kelley Bullard, Mark A Deka, Anfumbom Kfutwah, Javier Martin, Maël Bessaud, Lester M Shulman, Kaija Hawes, Ousmane M Diop, Ananda S Bandyopadhyay, Simona Zipursky, Cara C Burns
No abstract text is available yet for this article.
September 22, 2023: MMWR. Morbidity and Mortality Weekly Report
#11
JOURNAL ARTICLE
Ashley L Fowlkes, Francisco Nogareda, Annette Regan, Sergio Loayza, Jose Mendez Mancio, Lindsey M Duca, Paula Couto, Juliana Leite, Angel Rodriguez, Daniel Salas, Eduardo Azziz-Baumgartner
No abstract text is available yet for this article.
September 15, 2023: MMWR. Morbidity and Mortality Weekly Report
#12
JOURNAL ARTICLE
Peter M DeJonge, Carly Adams, Ian Pray, Melissa K Schussman, Rebecca B Fahney, Martin Shafer, Dagmara S Antkiewicz, Adélaïde Roguet
Wastewater surveillance has been used to assist public health authorities in tracking local transmission of SARS-CoV-2. The usefulness of wastewater surveillance to track community spread of other respiratory pathogens, including influenza virus and respiratory syncytial virus (RSV), is less clear. During the 2022-23 respiratory diseases season, concentrations of influenza A virus and RSV in wastewater samples in three major Wisconsin cities were compared with emergency department (ED) visits associated with these pathogens...
September 15, 2023: MMWR. Morbidity and Mortality Weekly Report
#13
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 15, 2023: MMWR. Morbidity and Mortality Weekly Report
#14
JOURNAL ARTICLE
Noah Berland, James Kababick, Cynthia Santos, Diane P Calello
No abstract text is available yet for this article.
September 15, 2023: MMWR. Morbidity and Mortality Weekly Report
#15
JOURNAL ARTICLE
Shannon McGinnis, Rebecca J Free, Jacqueline Burnell, Sridhar V Basavaraju, Trevor Kanaskie, Elizabeth J Hannapel, Nottasorn Plipat, Kimberly Warren, Chris Edens
In July 2022, the Pennsylvania Department of Health received two reports of laboratory-confirmed Legionnaires disease in patients who had recently received lung transplants from the same donor at a single Pennsylvania hospital. The donor's cause of death was freshwater drowning in a river, raising suspicion of potential donor-derived transmission, because Legionella bacteria naturally live in fresh water. Further investigation of patients receiving other organs from the same donor did not identify additional legionellosis cases...
September 15, 2023: MMWR. Morbidity and Mortality Weekly Report
#16
JOURNAL ARTICLE
Arran Hamlet, Katherine Begley, Shanna Miko, Laurie Stewart, Waimon Tellier, Joenice Gonzalez-De Leon, Hillary Booth, Soyeon Lippman, Amy Kahler, Alexis Roundtree, April Hatada, Scott Lindquist, Beth Melius, Marcia Goldoft, Mia Mattioli, Michelle Holshue
No abstract text is available yet for this article.
September 8, 2023: MMWR. Morbidity and Mortality Weekly Report
#17
JOURNAL ARTICLE
Rebecca Kahn, Lindsay Zielinski, Amber Gedlinske, Natoshia M Askelson, Christine Petersen, Andrew M Parker, Courtney A Gidengil, Alison P Albert, Angela J Jiles, Megan C Lindley, Miwako Kobayashi, Aaron M Scherer
Despite the availability of effective vaccines against pneumococcal disease, pneumococcus is a common bacterial cause of pneumonia, causing approximately 100,000 hospitalizations among U.S. adults per year. In addition, approximately 30,000 invasive pneumococcal disease (IPD) cases and 3,000 IPD deaths occur among U.S. adults each year. Previous health care provider surveys identified gaps in provider knowledge about and understanding of the adult pneumococcal vaccine recommendations, and pneumococcal vaccine coverage remains suboptimal...
September 8, 2023: MMWR. Morbidity and Mortality Weekly Report
#18
JOURNAL ARTICLE
Dawn Blackburn, Michael Drennon, Kelly Broussard, Andrea M Morrison, Danielle Stanek, Elizabeth Sarney, Christina Ferracci, Steve Huard, Wade Brennan, John Eaton, Sara Nealeigh, Natalie Barber, Rebecca A Zimler, Jeremy N Adams, Carina Blackmore, Manuel Gordillo, Robert Mercado, Harold Vore, Kelly Scanlan, Ian Motie, Leslie Stanfield, Ahmed Farooq, Kimberly Widel, Kelly Tomson, Nancy Kerr, John Nasir, Marshall Cone, Connor Rice, Thomas Larkin, Edwin Hernandez, Jennifer Bencie, Christopher R Lesser, Max Dersch, Samantha Ramirez-Lachmann, Marah Clark, Susan Rollo, Amira Bashadi, Ronald Tyler, Bethany Bolling, Brent Moore, Brendan Sullivan, Eric Fonken, Raquel Castillo, Yaziri Gonzalez, Gustavo Olivares, Kimberly E Mace, Dean Sayre, Audrey Lenhart, Alice Sutcliffe, Ellen Dotson, Claudia Corredor, Emma Rogers, Brian H Raphael, Sarah G H Sapp, Yvonne Qvarnstrom, Alison D Ridpath, Peter D McElroy
Eight cases of locally acquired, mosquito-transmitted (i.e., autochthonous) Plasmodium vivax malaria, which has not been reported in the United States since 2003, were reported to CDC from state health departments in Florida and Texas during May 18-July 17, 2023. As of August 4, 2023, case surveillance, mosquito surveillance and control activities, and public outreach and education activities continue in both states. U.S. clinicians need to consider a malaria diagnosis in patients with unexplained fever, especially in areas where autochthonous malaria has been recently reported, although the risk for autochthonous malaria in the United States remains very low...
September 8, 2023: MMWR. Morbidity and Mortality Weekly Report
#19
JOURNAL ARTICLE
Samuel Schildhauer, Kayla Saadeh, Josh Vance, Joshua Quint, Tarek Salih, Timothy Lo, Awa Keinde, Edwin Chojolan, Esther Gotlieb, Marisa Ramos, Eric Chapman, Philip Peters, Jessica Watson, Kelly A Johnson, Eric C Tang, Kathleen Jacobson, Robert Snyder
The effectiveness of 1 dose of JYNNEOS vaccine (modified vaccinia Ankara vaccine, Bavarian Nordic) against hospitalization for mpox (caused by Monkeypox virus), has been demonstrated; however, the impact of 2 doses on hospitalization risk, especially among persons infected with HIV, who are at higher risk for severe disease, is an important factor in evaluating vaccine effectiveness against mpox disease severity and Monkeypox virus infection. Surveillance data collected by the California Department of Public Health were used to evaluate whether receipt of 2 doses of JYNNEOS vaccine reduced the odds of hospitalization among persons with mpox...
September 8, 2023: MMWR. Morbidity and Mortality Weekly Report
#20
JOURNAL ARTICLE
Balcha G Masresha, Cynthia Hatcher, Emmaculate Lebo, Patricia Tanifum, Ado M Bwaka, Anna A Minta, Sebastien Antoni, Gavin B Grant, Robert T Perry, Patrick O'Connor
Worldwide, measles remains a major cause of disease and death; the highest incidence is in the World Health Organization African Region (AFR). In 2011, the 46 AFR member states established a goal of regional measles elimination by 2020; this report describes progress during 2017-2021. Regional coverage with a first dose of measles-containing vaccine (MCV) decreased from 70% in 2017 to 68% in 2021, and the number of countries with ≥95% coverage decreased from six (13%) to two (4%). The number of countries providing a second MCV dose increased from 27 (57%) to 38 (81%), and second-dose coverage increased from 25% to 41%...
September 8, 2023: MMWR. Morbidity and Mortality Weekly Report
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
